Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peritoneal Effusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06415500
What this trial is testing

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

Who this might be right for
Gynecologic Cancer
Anhui Provincial Hospital 9
Not applicableStudy completedNCT02891369
What this trial is testing

Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fondation Hôpital Saint-Joseph 30
Not applicableNot Yet RecruitingNCT06496919
What this trial is testing

A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors

Who this might be right for
Gastric Cancer
Wuhan University 300
Large-scale testing (Phase 3)UnknownNCT03475615
What this trial is testing

Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerStomach Neoplasms
Fudan University 215
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Not applicableWithdrawnNCT02477657
What this trial is testing

Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology

Who this might be right for
Refractory Malignant Ascites
Abramson Cancer Center at Penn Medicine
Not applicableWithdrawnNCT04076566
What this trial is testing

Malignant Ascites Alfapump® Study

Who this might be right for
Malignant Ascites
Sequana Medical N.V.
Early research (Phase 1)Ended earlyNCT02496286
What this trial is testing

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

Who this might be right for
Malignant Ascites
Eastern Regional Medical Center 10
Early research (Phase 1)UnknownNCT06200376
What this trial is testing

A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer

Who this might be right for
Malignant Ascites
West China Hospital 10
Not applicableEnrolling By InvitationNCT05745233
What this trial is testing

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Who this might be right for
Malignant Ascites
China Medical University Hospital 30
Early research (Phase 1)Looking for participantsNCT05477927
What this trial is testing

Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases

Who this might be right for
Malignant Peritoneal EffusionMalignant AscitesSerous Cavity Metastatises+1 more
Sichuan University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06432296
What this trial is testing

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Who this might be right for
Malignant Ascites
Wuhan YZY Biopharma Co., Ltd. 312
Testing effectiveness (Phase 2)Ended earlyNCT00265863
What this trial is testing

Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites

Who this might be right for
Metastatic Cancer
Masonic Cancer Center, University of Minnesota 1
Testing effectiveness (Phase 2)UnknownNCT01838538
What this trial is testing

Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy

Who this might be right for
Ovarian Cancer With Malignant Ascites
Chinese PLA General Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00396591
What this trial is testing

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian Neoplasms
Sanofi 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06991478
What this trial is testing

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Who this might be right for
Solid Tumor, Malignant Ascites
Tianjin Medical University Cancer Institute and Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01262612
What this trial is testing

Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion

Who this might be right for
Malignant AscitesMalignant Pleural Effusion
Radboud University Medical Center 12
Early research (Phase 1)Not Yet RecruitingNCT07615894
What this trial is testing

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

Who this might be right for
Advanced Solid TumorsMalignant Pleural EffusionsMalignant Ascites
WestVac Biopharma Co., Ltd. 9
Very early researchUnknownNCT05565014
What this trial is testing

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Who this might be right for
Malignant Pleural EffusionMalignant Peritoneal Effusion
Sheng Hu 90
Very early researchNot Yet RecruitingNCT07657416
What this trial is testing

NK521 in the Treatment of Advanced Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Ovarian CancerMalignant Ascites
Base Therapeutics (Shanghai) Co., Ltd. 18
Next Page